Zika Virus: Epidemiology, Clinical Manifestations, and Public Health Implications


Authors : Roofi; Safa Fatima; Fatima Umaira Saeed

Volume/Issue : Volume 9 - 2024, Issue 8 - August


Google Scholar : https://tinyurl.com/ymarjd49

Scribd : https://tinyurl.com/ye24nm79

DOI : https://doi.org/10.38124/ijisrt/24aug741

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 30 to 40 days to display the article.


Abstract : The Zika virus (ZIKV), a member of the Flavivirus genus, has garnered significant attention since its discovery in 1947, primarily due to its association with neurological complications and congenital anomalies. This abstract synthesises key insights into the epidemiology, aetiology, pathogenesis, diagnosis, management, and prognosis of Zika virus infection. ZIKV primarily spreads through Aedes mosquitoes but can also transmit through sexual contact, blood transfusions, and perinatal transmission. Its genetic diversity encompasses African and Asian lineages, with the Asian lineage implicated in severe outbreaks and congenital abnormalities. The virus's pathogenesis involves interactions with host cell receptors, viral replication, and evasion of immune responses. Clinical manifestations range from mild febrile illness to severe neurological disorders such as Guillain-Barré syndrome and congenital microcephaly. Differential diagnosis is crucial due to overlapping symptoms with other arboviruses and infectious diseases. Management focuses on supportive care and symptom management, with no specific antiviral therapy available. Prognosis varies, with most cases being self-limiting, but severe neurologic consequences and congenital abnormalities pose significant risks, especially during pregnancy. Public health measures emphasize vector control, travel advisories, and patient education. Further research is essential to understand the full spectrum of ZIKV pathogenesis, improve diagnostic capabilities, and develop effective preventive and therapeutic interventions.

Keywords : Transmissions, Hemorrhagic Syndrome, Arboviral Illness, Reye's Syndrome, Nucleocapsid Uncoating, Microcephaly, Japanese Encephalitis Virus (JEV).

References :

  1. Dick G.W., Kitchen S.F., and Haddow A.J. 1952. Zika virus. I. Isolations and serological specificity. Trans. R. Soc. Trop. Med. Hyg. 46(5): 509–520.
  2. MacNamara F.N. 1954. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans. R. Soc. Trop. Med. Hyg. 48(2): 139–145.
  3. Weaver S.C., Costa F., Garcia-Blanco M.A., Ko A.I., Ribeiro G.S., Saade G., et al. 2016. Zika virus: history, emergence, biology, and prospects for control. Antiviral. Res. 130: 69–80.
  4. Gatherer D. and Kohl A. 2016. Zika virus: a previously slow pandemic spreads rapidly through the Americas. J. Gen. Virol. 97(2): 269–273.
  5. Boyer S., Calvez E., Chouin-Carneiro T., Diallo D., and Failloux A.B. 2018. An overview of mosquito vectors of Zika virus. Microbes Infect. 20(11–12): 646–660.
  6. Petersen L.R., Jamieson D.J., Powers A.M., and Honein M.A. 2016. Zika virus. N. Engl. J. Med. 374(16): 1552–1563.
  7. Oehler E., Watrin L., Larre P., Leparc-Goffart I., Lastere S., Valour F., et al. 2014. Zika virus infection complicated by Guillain–Barre syndrome — case report, French Polynesia, December 2013. Eurosurveillance, 19(9): 20720.
  8. Schuler-Faccini L., Ribeiro E.M., Feitosa I.M., Horovitz D.D., Cavalcanti D.P., Pessoa A., et al. 2016. Possible association between Zika virus infection and microcephaly-Brazil, 2015. Morb. Mortal. Wkly. Rep. 65(3): 59–62.
  9. de Araújo T.V.B., Rodrigues L.C., de Alencar Ximenes R.A., de Barros Miranda-Filho D., Montarroyos U.R., de Melo A.P.L., et al. 2016. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect. Dis. 16(12): 1356–1363.
  10. Smithburn K.C. 1952. Neutralizing antibodies against certain recently isolated viruses in the sera of human beings residing in East Africa. J. Immunol. 69(2): 223–234.
  11. Dick G.W. 1953. Epidemiological notes on some viruses isolated in Uganda; Yellow fever, Rift valley fever, Bwamba fever, West Nile, Mengo, Semliki Forest, Bunyamwera, Ntaya, Uganda S and Zika viruses. Trans. R. Soc. Trop. Med. Hyg. 47(1): 13–48.
  12. Smithburn K.C., Taylor R.M., Rizk F., and Kader A. 1954a. Immunity to certain arthropod-borne viruses among indigenous residents of Egypt. Am. J. Trop. Med. Hyg. 3(1): 9-18.
  13. Moore D.L., Causey O.R., Carey D.E., Reddy S., Cooke A.R., Akinkugbe F.M., et al. 1975. Arthropod-borne viral infections of man in Nigeria, 1964-1970. Ann. Trop. Med. Parasitol. 69(1): 49–64.
  14. Marchette N.J., Garcia R., and Rudnick A. 1969. Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am. J. Trop. Med. Hyg. 18(3): 411–415.
  15. Olson J.G., Ksiazek T.G., Suhandiman, and Triwibowo 1981. Zika virus, a cause of fever in central Java, Indonesia. Trans. R. Soc. Trop. Med. Hyg. 75(3): 389–393.
  16. Smithburn K.C., Kerr J.A., and Gatne P.B. 1954b. Neutralizing antibodies against certain viruses in the sera of residents of India. J. Immunol. 72(4): 248–257.
  17. Smithburn K.C. 1954. Neutralizing antibodies against arthropod-borne viruses in the sera of long-time residents of Malaya and Borneo. Am. J. Epidemiol. 59(2): 157–163.
  18. Hammon W.M., Schrack W.D. Jr, and Sather G.E. 1958. Serological survey for arthropod-borne virus infections in the Philippines. Am. J. Trop. Med. Hyg. 7(3): 323–328.
  19. Pond W.L. 1963. Arthropod-borne virus antibodies in sera from residents of South-East Asia. Trans. R. Soc. Trop. Med. Hyg. 57: 364–371.
  20. Darwish M.A., Hoogstraal H., Roberts T.J., Ahmed I.P., and Omar F. 1983. A sero-epidemiological survey for certain arboviruses (Togaviridae) in Pakistan. Trans. R. Soc. Trop. Med. Hyg. 77(4): 442–445.
  21. W.G. Bearcroft. Zika virus infection experimentally induced in a human volunteer. Trans. R. Soc. Trop. Med. Hyg., 50 (1956), pp. 442-448.
  22. J. Cerbino-Neto, E.C. Mesquita, T.M. Souza, V. Parreira, B.B. Wittlin, B. Durovni, M.C.Lemos, A. Vizzoni, A.M. Bispo de Filippis, S.A.Sampaio, S. Goncalves Bde, F.A. Bozza. Clinical manifestations of Zika virus infection, Rio de Janeiro, Brazil, 2015. Emerg. Infect. Dis., 22 (2016), pp. 1318-1320.
  23. M.R. Duffy, T.H. Chen, W.T. Hancock, A.M. Powers, J.L. Kool, R.S. Lanciotti, M. Pretrick, M.Marfel, S. Holzbauer, C. Dubray, L. Guillaumot, A.Griggs, M. Bel, A.J. Lambert, J. Laven, O. Kosoy, A.Panella, B.J. Biggerstaff, M. Fischer, E.B. Hayes. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med., 360 (2009), pp. 2536-2543.
  24. H.M. Lazear, M.S. Diamond. Zika virus: new clinical syndromes and its emergence in the western hemisphere. J. Virol., 90 (2016), pp. 4864-4875.
  25. D. Musso, T. Nhan, E. Robin, C. Roche, D. Bierlaire, K. Zisou, A. Shan Yan, V.M. Cao-Lormeau, J. Broult.Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Euro Surveill., 19 (2014), p. 20761.
  26. P. Brasil, J.P. Pereira Jr., M.E. Moreira, R.M. Ribeiro Nogueira, L. Damasceno, M.Wakimoto, R.S. Rabello, S.G. Valderramos, U.A.Halai, T.S. Salles, A.A. Zin, D. Horovitz, P. Daltro, M.Boechat, C. Raja Gabaglia, P. Carvalho de Sequeira, J.H. Pilotto, R. Medialdea-Carrera, D. Cotrim da Cunha, L.M. Abreu de Carvalho, M. Pone, A.Machado Siqueira, G.A. Calvet, A.E. Rodrigues Baião, E.S. Neves, P.R. Nassar de Carvalho, R.H.Hasue, P.B. Marschik, C. Einspieler, C. Janzen, J.D.Cherry, A.M. Bispo de Filippis, K. Nielsen-Saines.Zika virus infection in pregnant women in Rio de Janeiro. N. Engl. J. Med., 375 (2016), pp. 2321-2334.
  27. V.M. Cao-Lormeau, C. Roche, A.Teissier, E. Robin, A.L. Berry, H.P. Mallet, A.A. Sall, D.Musso.Zika virus, French Polynesia, South Pacific, 2013. Emerg. Infect. Dis., 20 (2014), pp. 1085-1086.
  28. F.N. Macnamara.Trans. R. Soc. Trop. Med. Hyg., 48 (1954), pp. 139-145.
  29. L. Zammarchi, G. Stella, A.Mantella, D. Bartolozzi, D. Tappe, S. Gunther, L.Oestereich, D. Cadar, C. Munoz-Fontela, A.Bartoloni, J. Schmidt-Chanasit. Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications. J. Clin. Virol., 63 (2015), pp. 32-35.
  30. B.D. Foy, K.C. Kobylinski, J.L. Chilson Foy, B.J. Blitvich, A. Travassos da Rosa, A.D. Haddow, R.S.Lanciotti, R.B. Tesh.Probable non-vector-borne transmission of Zika virus, Colorado, USA. Emerg. Infect. Dis., 17 (2011), pp. 880-882.
  31. D. Musso, C. Roche, E. Robin, T. Nhan, A. Teissier, V.M. Cao-Lormeau.Potential sexual transmission of Zika virus. Emerg. Infect. Dis., 21 (2015), pp. 359-361.
  32. D. Tappe, S. Nachtigall, A. Kapaun, P.Schnitzler, S. Gunther, J. Schmidt-Chanasit. Acute Zika virus infection after travel to Malaysian Borneo, September 2014. Emerg. Infect. Dis., 21 (2015), pp. 911-913.
  33. S. Chraibi, F. Najioullah, C. Bourdin, J.Pegliasco, C. Deligny, D. Resiere, J.C. Meniane. Two cases of thrombocytopenic purpura at onset of Zika virus infection. J. Clin. Virol., 83 (2016), pp. 61-62.
  34. J.W. Duijster, A. Goorhuis, P.J. van Genderen, L.G. Visser, M.P. Koopmans, J.H.Reimerink, M.P. Grobusch, A.A. van der Eijk, J.H. van den Kerkhof, C.B. Reusken, S.J. Hahne, Dutch ZIKV Study Team. Zika virus infection in 18 travellers returning from Surinam and the Dominican Republic, the Netherlands, November 2015–March 2016.Infection, 44 (2016), pp. 797-802.
  35. O. Karimi, A. Goorhuis, J. Schinkel, J.Codrington, S.G. Vreden, J.S. Vermaat, C. Stijnis, M.P.Grobusch. Thrombocytopenia and subcutaneous bleedings in a patient with Zika virus infection. Lancet, 387 (2016), pp. 939-940.
  36. T.M. Sharp, J. Munoz-Jordan, J. Perez-Padilla, M.I. Bello-Pagan, A. Rivera, D.M. Pastula, J.L. Salinas, J.H. Martinez Mendez, M. Mendez, A.M.Powers, S. Waterman, B. Rivera-Garcia.Zika virus infection associated with severe thrombocytopenia.Clin. Infect. Dis., 63 (2016), pp. 1198-1201.
  37. A. Creange. Guillain–Barre syndrome: 100 years on. Rev. Neurol., 172 (2016), pp. 770-.
  38. J.A. Goodfellow,H.J.Willison.Guillain–Barre syndrome: a century of progress.Nat. Rev. Neurol., 12 (2016), pp. 723-731.
  39. F.J. Carod-Artal, O. Wichmann, J.Farrar, J. Gascon. Neurological complications of dengue virus infection. Lancet Neurol., 12 (2013), pp. 906-919.
  40. D.M. Ralapanawa, S.A. Kularatne, W.A. Jayalath. Guillain–Barre syndrome following dengue fever and literature review.BMC Res. Notes, 8 (2015), p. 729.
  41. O. Simon, S. Billot, D. Guyon, M. Daures, E. Descloux, A.C. Gourinat, N. Molko, M. Dupont-Rouzeyrol. Early Guillain–Barre syndrome associated with acute dengue fever. J. Clin. Virol., 77 (2016), pp. 29-31.
  42. N. Broutet, F. Krauer, M. Riesen, A.Khalakdina, M. Almiron, S. Aldighieri, M. Espinal, N.Low, C. Dye.Zika virus as a cause of neurologic disorders.N. Engl. J. Med., 374 (2016), pp. 1506-1509.
  43. B. Roze, F. Najioullah, J.L. Ferge, K.Apetse, Y. Brouste, R. Cesaire, C. Fagour, L. Fagour, P. Hochedez, S. Jeannin, J. Joux, H. Mehdaoui, R.Valentino, A. Signate, A. Cabie, GBS Zika Working Group.Zika virus detection in urine from patients with Guillain-Barre syndrome on Martinique, January 2016.Euro Surveill., 21 (2016), p. 30154.
  44. D.L. Thomas, T.M. Sharp, J. Torres, P.A.Armstrong, J. Munoz-Jordan, K.R. Ryff, A. Martinez-Quinones, J. Arias-Berrios, M. Mayshack, G.J.Garayalde, S. Saavedra, C.A. Luciano, M. Valencia-Prado, S. Waterman, B. Rivera-Garcia.Local transmission of Zika virus — Puerto Rico, November 23, 2015–January 28, 2016.
  45. V.M. Cao-Lormeau, A. Blake, S. Mons, S. Lastere, C. Roche, J. Vanhomwegen, T. Dub, L. Baudouin, A. Teissier, P. Larre, A.L. Vial, C. Decam, V. Choumet, S.K. Halstead, H.J. Willison, L. Musset, J.C. Manuguerra, P. Despres, E. Fournier, H.P. Mallet, D. Musso, A. Fontanet, J. Neil, F. Ghawche. Guillain–Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case–control study. Lancet, 387 (2016), pp. 1531-1539.
  46. Z.A. Klase, S. Khakhina, B. Schneider Ade, M.V. Callahan, J. Glasspool-Malone, R. Malone.Zika fetal neuropathogenesis: etiology of a viral syndrome. PLoS Negl. Trop. Dis., 10 (2016), Article e0004877.
  47. A. Panchaud, M. Stojanov, A. Ammerdorffer, M. Vouga, D. Baud. Emerging role of Zika virus in adverse fetal and neonatal outcomes. Clin. Microbiol. Rev., 29 (2016), pp. 659-694.
  48. B.L. Tang. Zika virus as a causative agent for primary microencephaly: the evidence so far. Arch. Microbiol., 198 (2016), pp. 595-601
  49. D. Alcantara, M. O'Driscoll. Congenital microcephaly. Am. J. Med. Genet. C. Semin. Med. Genet., 166C (2014), pp. 124-139.
  50. S. Passemard, A.M. Kaindl, A. Verloes. Microcephaly. Handb. Clin. Neurol., 111 (2013), pp. 129-141.
  51. C.G. Woods. Human microcephaly. Curr. Opin. Neurobiol., 14 (2004), pp. 112-117.
  52. L. Dahlgren, R.D. Wilson. Prenatally diagnosed microcephaly: a review of etiologies.Fetal Diagn. Ther., 16 (2001), pp. 323-326.
  53. M. von der Hagen, M. Pivarcsi, J. Liebe, H. von Bernuth, N. Didonato, J. B. Hennermann, C. Buhrer, D. Wieczorek, A.M. Kaindl. Diagnostic approach to microcephaly in childhood: a two-center study and review of the literature. Dev. Med. Child Neurol., 56 (2014), pp. 732-741.
  54. M. De Santis, A.F. Cavaliere, G. Straface, A. Caruso. Rubella infection in pregnancy. Reprod. Toxicol., 21 (2006), pp. 390-398.
  55. W.S. Webster Teratogen update: congenital rubella. Teratology, 58 (1998), pp. 13-23.
  56. E.J. Plosa, J.C. Esbenshade, M.P. Fuller, J.H. Weitkamp. Cytomegalovirus infection. Pediatr. Rev., 33 (2012), pp. 156-163.
  57. E.C. Swanson, M.R. Schleiss. Congenital cytomegalovirus infection: new prospects for prevention and therapy. Pediatr. Clin. North Am., 60 (2013), pp. 335-349.
  58. L. Schuler-Faccini, E.M. Ribeiro, I.M. Feitosa, D. D. Horovitz, D. P. Cavalcanti, A. Pessoa, M.J. Doriqui, J.I. Neri, J.M. Neto, H. Y. Wanderley, M. Cernach, A.S. El-Husny, M.V. Pone, C.L. Serao, M.T. Sanseverino, Brazilian Medical Genetics Society–Zika Embryopathy Task Force. Possible association between Zika virus infection and microcephaly — Brazil, 2015. MMWR Morb. Mortal. Wkly. Rep., 65 (2016), pp. 59-62.
  59. M.C. Magalhaes-Barbosa, A. Prata-Barbosa, J.R. Robaina, C.E. Raymundo, F.Lima-Setta, A.J. Cunha. Trends of the microcephaly and Zika virus outbreak in Brazil, January–July 2016. Travel Med. Infect. Dis., 14 (2016), pp. 458-463.
  60. S. Cauchemez, M. Besnard, P. Bompard, T. Dub, P. Guillemette-Artur, D. Eyrolle-Guignot, H. Salje, M.D. Van Kerkhove, V. Abadie, C. Garel, A. Fontanet, H.P. Mallet. Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study. Lancet, 387 (2016), pp. 2125-2132.
  61. J.M. Jouannic, S. Friszer, I. Leparc-Goffart, C. Garel, D. Eyrolle-Guignot. Zika virus infection in French Polynesia.Lancet, 387 (2016), pp. 1051-1052.
  62. G. Calvet, R.S. Aguiar, A.S. Melo, S.A.Sampaio, I. de Filippis, A. Fabri, E.S. Araujo, P.C. de Sequeira, M.C. de Mendonca, L. de Oliveira, D. A. Tschoeke, C.G. Schrago, F.L. Thompson, P. Brasil, F. B. Dos Santos, R.M. Nogueira, A. Tanuri, A.M. de Filippis. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect. Dis., 16 (2016), pp. 653-660.
  63. D. Meaney-Delman, S.L. Hills, C. Williams, R.R. Galang, P. Iyengar, A. K. Hennenfent, I.B. Rabe, A. Panella, T. Oduyebo, M. A. Honein, S. Zaki, N. Lindsey, J.A. Lehman, N. Kwit, J. Bertolli, S. Ellington, I. Igbinosa, A.A. Minta, E. E. Petersen, P. Mead, S.A. Rasmussen, D.J. Jamieson. Zika virus infection among U.S. pregnant travelers — August 2015–February 2016. MMWR Morb. Mortal. Wkly. Rep., 65 (2016), pp. 211-214.
  64. M. Sarno, G.A. Sacramento, R. Khouri, M.S. do Rosario, F. Costa, G. Archanjo, L.A. Santos, N. Nery Jr., N. Vasilakis, A.I. Ko, A.R. de Almeida. Zika virus infection and stillbirths: a case of hydrops fetalis, hydranencephaly and fetal demise. PLoS Negl. Trop. Dis., 10 (2016), Article e0004517.
  65. M. Besnard, S. Lastere, A. Teissier, V. Cao-Lormeau, D. Musso. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill., 19 (2014), p. 20751.
  66. D. Butler. First Zika-linked birth defects detected in Colombia. Nature, 531 (2016), p. 153.
  67. R.W. Driggers, C.Y. Ho, E.M. Korhonen, S. Kuivanen, A.J. Jaaskelainen, T. Smura, A. Rosenberg, D.A. Hill, R.L. DeBiasi, G. Vezina, J. Timofeev, F.J. Rodriguez, L. Levanov, J. Razak, P.Iyengar, A. Hennenfent, R. Kennedy, R. Lanciotti, A.du Plessis, O. Vapalahti. Zika virus infection with prolonged maternal viremia and fetal brain abnormalities. N. Engl. J. Med., 374 (2016), pp. 2142-2151.
  68. N.R. Faria, S. Azevedo Rdo, M.U. Kraemer, R. Souza, M.S. Cunha, S.C. Hill, J. Theze, M. B. Bonsall, T.A. Bowden, I. Rissanen, I.M. Rocco, J. S. Nogueira, A.Y. Maeda, F.G. Vasami, F.L. Macedo, A. Suzuki, S.G. Rodrigues, A.C. Cruz, B.T. Nunes, D. B. Medeiros, D.S. Rodrigues, A.L. Nunes Queiroz, E. V. da Silva, D.F. Henriques, E.S. Travassos da Rosa, C.S.de Oliveira, L.C. Martins, H.B. Vasconcelos, L.M. Casseb, B. Simith Dde, J.P. Messina, L. Abade, J. Lourenco, L. Carlos Junior Alcantara, M.M. de Lima, M. Giovanetti, S.I. Hay, R.S. de Oliveira, S. Lemos Pda, L.F. de Oliveira, C.P. de Lima, S.P. da Silva, J.M.de Vasconcelos, L. Franco, J.F. Cardoso, J.L. Vianez-Junior, D. Mir, G. Bello, E. Delatorre, K. Khan, M. Creatore, G.E. Coelho, W.K. de Oliveira, R. Tesh, O. G. Pybus, M.R. Nunes, P.F. Vasconcelos. Zika virus in the Americas: early epidemiological and genetic findings. Science, 352 (2016), pp. 345-349.
  69. R.B. Martines, J. Bhatnagar, M. K. Keating, L. Silva-Flannery, A. Muehlenbachs, J. Gary, C. Goldsmith, G. Hale, J. Ritter, D. Rollin, W.J. Shieh, K.G. Luz, A.M. Ramos, H.P. Davi, W. Kleber de Oliveria, R. Lanciotti, A. Lambert, S. Zaki. Notes from the field: evidence of Zika virus infection in brain and placental tissues from two congenitally infected newborns and two fetal losses — Brazil, 2015. MMWR Morb. Mortal. Wkly. Rep., 65 (2016), pp. 159-160.
  70. J. Mlakar, M. Korva, N. Tul, M. Popovic, M. Poljsak-Prijatelj, J. Mraz, M. Kolenc, K. Resman Rus, T. Vesnaver Vipotnik, V. Fabjan Vodusek, A. Vizjak, J. Pizem, M. Petrovec, T. Avsic Zupanc. Zika virus associated with microcephaly. N. Engl. J. Med., 374 (2016), pp. 951-958.
  71. M.T. Cordeiro, L.J. Pena, C.A. Brito, L.H.Gil, E.T. Marques. Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil. Lancet, 387 (2016), pp. 1811-1812.
  72. T.V. de Araujo, L.C. Rodrigues, R.A. de Alencar Ximenes, D. de Barros Miranda-Filho, U.R.Montarroyos, A.P. de Melo, S. Valongueiro, M.F. de Albuquerque, W.V. Souza, C. Braga, S.P. Filho, M.T.Cordeiro, E. Vazquez, D. Di Cavalcanti Souza Cruz, C.M. Henriques, L.C. Bezerra, P.M. da Silva Castanha, R. Dhalia, E.T. Marques-Junior, C.M.Martelli, Investigators from the Microcephaly Epidemic Research Group, Brazilian Ministry of Health, Pan American Health Organization, Instituto de Medicina Integral Professor Fernando Figueira, State Health Department of Pernambuco. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case–control study. Lancet Infect. Dis., 16 (2016), pp. 1356-1363.
  73. 73 G. Carteaux, M. Maquart, A. Bedet, D.Contou, P. Brugieres, S. Fourati, L. Cleret de Langavant, T. de Broucker, C. Brun-Buisson, I.Leparc-Goffart, A. Mekontso Dessap. Zika virus associated with meningoencephalitis. N. Engl. J. Med., 374 (2016), pp. 1595-1596.
  74. S. Mecharles, C. Herrmann, P.Poullain, T.H. Tran, N. Deschamps, G. Mathon, A.Landais, S. Breurec, A. Lannuzel. Acute myelitis due to Zika virus infection. Lancet, 387 (2016), p. 1481.
  75. D. Musso, D.J. Gubler. Zika virus. Clin. Microbiol. Rev., 29 (2016), pp. 487-524.
  76. S.A. Rasmussen, D.J. Jamieson, M. A. Honein, L.R. Petersen. Zika virus and birth defects — reviewing the evidence for causality. N. Engl. J. Med., 374 (2016), pp. 1981-1987.

The Zika virus (ZIKV), a member of the Flavivirus genus, has garnered significant attention since its discovery in 1947, primarily due to its association with neurological complications and congenital anomalies. This abstract synthesises key insights into the epidemiology, aetiology, pathogenesis, diagnosis, management, and prognosis of Zika virus infection. ZIKV primarily spreads through Aedes mosquitoes but can also transmit through sexual contact, blood transfusions, and perinatal transmission. Its genetic diversity encompasses African and Asian lineages, with the Asian lineage implicated in severe outbreaks and congenital abnormalities. The virus's pathogenesis involves interactions with host cell receptors, viral replication, and evasion of immune responses. Clinical manifestations range from mild febrile illness to severe neurological disorders such as Guillain-Barré syndrome and congenital microcephaly. Differential diagnosis is crucial due to overlapping symptoms with other arboviruses and infectious diseases. Management focuses on supportive care and symptom management, with no specific antiviral therapy available. Prognosis varies, with most cases being self-limiting, but severe neurologic consequences and congenital abnormalities pose significant risks, especially during pregnancy. Public health measures emphasize vector control, travel advisories, and patient education. Further research is essential to understand the full spectrum of ZIKV pathogenesis, improve diagnostic capabilities, and develop effective preventive and therapeutic interventions.

Keywords : Transmissions, Hemorrhagic Syndrome, Arboviral Illness, Reye's Syndrome, Nucleocapsid Uncoating, Microcephaly, Japanese Encephalitis Virus (JEV).

CALL FOR PAPERS


Paper Submission Last Date
30 - November - 2025

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe